LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

LLY

1,072.2

-0.38%↓

JNJ

207.49

-0.14%↓

ABBV

229.96

-0.08%↓

UNH

329.85

+0.64%↑

AZN

92.7

+0.22%↑

Search

McKesson Corp

Ouvert

SecteurSoins de santé

826.42 -0.05

Résumé

Variation du prix de l'action

24h

Actuel

Min

825.01

Max

829.21

Chiffres clés

By Trading Economics

Revenu

426M

1.2B

Ventes

5.3B

103B

P/E

Moyenne du Secteur

25.575

78.892

BPA

9.86

Rendement du dividende

0.36

Marge bénéficiaire

1.173

Employés

43,000

EBITDA

212M

1.5B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+14.01% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.36%

2.38%

Prochains Résultats

4 févr. 2026

Date du Prochain Dividende

2 janv. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-235M

102B

Ouverture précédente

826.47

Clôture précédente

826.42

Sentiment de l'Actualité

By Acuity

39%

61%

114 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

McKesson Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 déc. 2025, 21:41 UTC

Acquisitions, Fusions, Rachats

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 déc. 2025, 14:57 UTC

Acquisitions, Fusions, Rachats

Accenture to Acquire Cabel Industry from Fibonacci Group

25 déc. 2025, 23:42 UTC

Market Talk

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 déc. 2025, 23:40 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 déc. 2025, 00:20 UTC

Acquisitions, Fusions, Rachats

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 déc. 2025, 22:22 UTC

Acquisitions, Fusions, Rachats

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 déc. 2025, 21:26 UTC

Acquisitions, Fusions, Rachats

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 déc. 2025, 19:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24 déc. 2025, 19:35 UTC

Market Talk

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 déc. 2025, 19:09 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

24 déc. 2025, 19:09 UTC

Market Talk
Acquisitions, Fusions, Rachats

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 déc. 2025, 19:06 UTC

Market Talk

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 déc. 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 déc. 2025, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

24 déc. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 déc. 2025, 17:08 UTC

Acquisitions, Fusions, Rachats

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 déc. 2025, 16:53 UTC

Acquisitions, Fusions, Rachats

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 déc. 2025, 16:31 UTC

Market Talk
Acquisitions, Fusions, Rachats

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 déc. 2025, 16:28 UTC

Acquisitions, Fusions, Rachats

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 déc. 2025, 16:17 UTC

Market Talk

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 déc. 2025, 15:33 UTC

Acquisitions, Fusions, Rachats

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 déc. 2025, 15:30 UTC

Acquisitions, Fusions, Rachats

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 déc. 2025, 15:19 UTC

Acquisitions, Fusions, Rachats

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 déc. 2025, 14:49 UTC

Acquisitions, Fusions, Rachats

Mexico's Ollamani Sells Stake in Azteca Stadium

24 déc. 2025, 14:19 UTC

Market Talk

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 déc. 2025, 14:08 UTC

Acquisitions, Fusions, Rachats

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 déc. 2025, 14:06 UTC

Market Talk

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 déc. 2025, 13:24 UTC

Market Talk

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 déc. 2025, 12:59 UTC

Acquisitions, Fusions, Rachats

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 déc. 2025, 12:51 UTC

Acquisitions, Fusions, Rachats

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Comparaison

Variation de prix

McKesson Corp prévision

Objectif de Prix

By TipRanks

14.01% hausse

Prévisions sur 12 Mois

Moyen 942.18 USD  14.01%

Haut 1,000 USD

Bas 880 USD

Basé sur 14 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

14 ratings

12

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

681.92 / 707.28Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

No Evidence

Long Terme

No Evidence

Sentiment

By Acuity

114 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat